SEC Form 4 · accession 0001171843-15-000637
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve E Wheeler
Director
Period of report
Feb 3, 2015
Accepted (ET)
Feb 5, 2015 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 3, 2015 | A | 1,511 | $0.00 | A | 30,380 | D | |
| Common StockF2 | Feb 4, 2015 | A | 1,275 | $14.33 | A | 31,655 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2 | $14.33 | Feb 4, 2015 | M | 1,275 | D | — | Apr 25, 2015 | Common Stock | 1,275 | 0 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in four equal annual installments beginning February 3, 2016.
- F2Exercise of stock options granted on April 25, 2005 with an expiration date of April 25, 2015.